In response to the enactment of Senate File 296 during the 2021 legislative session which codifies the authorization of pharmacists to provide patient care and drug therapy management under a collaborative pharmacy practice agreement (β€œCPA”) with one or more practitioners, the Board is seeking pre-Notice comments on draft rules relating to CPAs. The draft rules may be found on the Board’s website

Please submit comments relating to the CPA draft rules no later than July 29, 2021 to Sue Mears at